February 06, 2026 05:59 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Big call from RBI: Repo rate stays at 5.25%, neutral stance continues | RG Kar scam twist: Court issues non-bailable warrant against whistle-blower Akhtar Ali | Court snub for Vijay: Madras HC rejects plea in ₹1.5 crore tax case | ‘We never said no’: Suryakumar Yadav says India ready for Pakistan clash at T20 World Cup | Supreme Court orders Mamata govt to clear pending dues | ‘India is free to buy oil from anyone’: Russia fires back at Trump’s crude deal claim | ‘Justice crying behind closed doors’: Mamata Banerjee slams ECI in Supreme Court, CJI Kant assures solution | Mummy, Papa, sorry: Three sisters jump to death after parents object to online gaming | Supreme Court raps Meta, WhatsApp: ‘Theft of private information, won’t allow its use’ | ‘Completely surrendered’: Congress slams Modi after Trump’s trade deal move

Covid-19: I-Sec supports IIT Kanpur to develop indigenized, portable, affordable ventilators

| @indiablooms | Apr 15, 2020, at 05:20 pm

Mumba/IBNS: ICICI Securities, India’s leading retail-led equity franchise today said, as a part of its CSR initiatives, it has joined hands with the prestigious Indian Institute of Technology Kanpur as a ‘Technology Development Partner’, to develop indigenized, high-end yet affordable invasive ventilators.

The ventilators are essential life saving devices that are critical for COVID-19 affected patients. It becomes critical for a country like India to start designing and manufacturing completely indigenized and low-cost invasive ventilators. To achieve this, the country must encourage Indian innovators to come to the fore, especially nimble-footed start-ups.

IIT-Kanpur, along with Nocca Robotics (a start-up incubated at Start-up Incubation and Innovation Centre IIT Kanpur - SIIC IIT Kanpur), has created a consortium with bio-medical engineers, doctors, R & D leaders, supply chain, MedTech business heads, etc., to develop a completely indigenized, invasive, portable and affordable mechanical ventilator. Under this fast-track project, by mid-May 2020, the product will be ready for market, post design, development and testing of prototypes at multiple centres.

“Covid-19 has created a pandemic and has affected the entire ecosystem. While the research work on diagnosis and cure are being done, the immediate need is ensuring affordable and low-cost life saving devices. At ICICI Securities, healthcare is one important area that we focus on CSR. We are happy to partner with IIT Kanpur, as part of our CSR initiative, in the R&D and testing of prototypes of indigenized, portable affordable and invasive ventilators. The project team has some of the brightest technical minds and they have set for themselves a very tight deadline so that the nation at large is benefitted. We are hopeful that the project meets the expectations of price and functionality,” said Vijay Chandok, MD & CEO, ICICI Securities.

“At IIT Kanpur, we are doing our bit towards global efforts on fighting the Covid-19 pandemic. We learnt that ventilators will be in short supply as the number of affected patients rise and our team rose to the challenge by taking on themselves the responsibility to design ground-up an affordable yet fully functional ventilator. We are happy to partner with ICICI Securities as a Technology Development Partner to bring this project to light,” said Prof. Abhay Karandikar, Director of IIT Kanpur.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.